Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia

After analyzing treatment patterns in chronic lymphocytic leukemia (CLL) (objective 1), we investigated the relative effectiveness of ibrutinib versus other commonly used treatments (objective 2) in patients with treatment-naïve and relapsed/refractory CLL, comparing patient-level data from two rand...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Ann Hematol
Autores principales: Salles, Gilles, Bachy, Emmanuel, Smolej, Lukas, Simkovic, Martin, Baseggio, Lucile, Panovska, Anna, Besson, Hervé, Healy, Nollaig, Garside, Jamie, Iraqi, Wafae, Diels, Joris, Pick-Lauer, Corinna, Spacek, Martin, Urbanova, Renata, Lysak, Daniel, Hermans, Ruben, Lundbom, Jessica, Callet-Bauchu, Evelyne, Doubek, Michael
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6900267/
https://ncbi.nlm.nih.gov/pubmed/31745601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-019-03830-8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares